DSCF yields 3.17% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, DSCF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DSCF + MRK for your $10,000?
The fund is an actively-managed ETF that seeks to achieve its investment objective by investing in a portfolio of other large, broad-based ETFs that the sub-adviser believes can reduce the fund’s relative stock and bond risks when compared to a traditional diversified market cap-weighted index fund. The fund’s allocation between broad-based U.S. equity ETFs and broad-based foreign focused equity ETFs will generally align with the then-current market cap weighting of the U.S. and foreign equity markets. The fund’s bond sleeve will be comprised of between two and four underlying ETFs.
Full DSCF Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.